Maitake mushroom supplementation modulates upper respiratory symptoms and immune responses in healthy adults: a randomized, double-blind, placebo-controlled trial
Open Access
- 21 September 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 17 (18) , 8114-8126
Abstract
Maitake Y10M supplementation may reduce selected URTI-related symptom burden and modulate innate immune responses in healthy adults.Keywords
This publication has 43 references indexed in Scilit:
- Human natural killer cells: Form, function, and developmentJournal of Allergy and Clinical Immunology, 2022
- Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in healthy subjects: a systematic review and meta-analysisEuropean Journal of Nutrition, 2021
- Decoding the Heterogeneity of Human Dendritic Cell SubsetsTrends in Immunology, 2020
- Comprehensive Phenotyping of Human Dendritic Cells and MonocytesCytometry Part A, 2020
- Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II studyCancer Immunology, Immunotherapy, 2014
- Oral administration of soluble β‐glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor‐bearing miceInternational Journal of Cancer, 2012
- Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infectionsNutrition, 2012
- A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effectsJournal of Cancer Research and Clinical Oncology, 2009
- Innate immune response to viral infectionCytokine, 2008
- UPPER RESPIRATORY TRACT INFECTION2006